Click here to listen to the ASBMR Webinar Panel: Treating Patients with Osteoporosis During the COVID-19 Pandemic that took place on Tuesday, April 14, 2020. The webinar featured a panel of clinical experts in bone discussing timely topics related to osteoporosis treatment and the COVID-19 pandemic, including:
- Prolia® (denosumab) and the immune system
- Approaches to transitioning patients from Prolia® (denosumab)
- Timing of Evenity® (romosozumab) and possible transition to other treatments
- Transition from skeletal anabolics to antiresorptives
Amgen recommends the use of its products only in accordance with the Food and Drug Administration (FDA)-approved prescribing information. Please refer to the full prescribing information for approved product labeling and important safety information - https://www.amgenmedinfo.com/Home
Access to this recording is free. To access the recording, create an account on www.asbmr.org, if you do not already have one, and login to listen.